CD44 and osteosarcoma: The results in osteosarcoma cell lines with constitutive knockout of CD44 gene by CRISPR/Cas9 system verified that CD44 mediates migration, invasion, proliferation and drug resistance to doxorubicin in osteosarcoma cells.